GlassScriptPhysician profile
Lyda D Pung
NPI 1518385046
$2,196.60
in general payments reported to CMS, 2019-2025
27 companies · $163 in 2025
The $163 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $192 · 2021: $621 · 2022: $418 · 2023: $297 · 2024: $99.92 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $515 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $514.52 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $602.30 | 2019-2022 | |
| Amgen INC. | $284.27 | 2019-2023 | Prolia, Evenity |
| Davol INC. | $149.28 | 2023 | Arista Ah Flexitip |
| Coopersurgical, INC. | $136.46 | 2021-2024 | Paragard T 380a |
| Intuitive Surgical, INC. | $109.26 | 2022 | |
| Organon LLC | $80.87 | 2022-2025 | Nexplanon |
| Conmed Corporation | $71.43 | 2022 | |
| Millicent US INC | $67.27 | 2024-2025 | Intrarosa, Femring |
| Mayne Pharma Commercial LLC | $61.56 | 2023-2025 | |
| Agile Therapeutics, INC. | $60.32 | 2021 | |
| Allergan, INC. | $60.20 | 2019-2020 | |
| Therapeuticsmd, INC. | $56.12 | 2019-2022 | |
| Pfizer INC. | $50.94 | 2023-2025 | |
| Avion Pharmaceuticals | $49.81 | 2020-2021 | |
| Exeltis, USA INC. | $49.65 | 2021-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $47.37 | 2020-2024 | |
| Novo Nordisk INC | $39.89 | 2019-2023 | Wegovy, Saxenda |
| Sumitomo Pharma America, INC. | $39.85 | 2023 | Myfembree |
| Hologic Sales and Service, LLC | $36.81 | 2022-2025 | Thinprep 2000 Processor, Aptima |
| Lupin INC. | $28.57 | 2019 | |
| Lilly USA, LLC | $17.94 | 2025 | Zepbound |
| Janssen Biotech, INC. | $17.86 | 2025 | Tremfya |
| Vertex Pharmaceuticals Incorporated | $17.69 | 2025 | |
| Amag Pharmaceuticals, INC. | $17.63 | 2019 | |
| Radius Health, INC. | $17.52 | 2019 | |
| Duchesnay USA Incorporated | $13.10 | 2019 | |
| Minerva Surgical, INC | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lyda Pung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.